Vaccinology During and After COVID-19
Vaccinology During and After COVID-19
批准号:
10753782
负责人:
TERRY L. SHEPPARD
金额:
$0.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-07-20 至 2024-06-30
关键词:
2019-nCoVAffectAntibody ResponseB-LymphocytesCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 vaccineClinical MedicineCollaborationsCommunicable DiseasesDevelopmentDimensionsEconomicsEducational workshopEnsureEquityEthicsFutureHumanImmunityImmunologyIndustrializationInequalityInternationalInvestmentsKnowledgeLearningLicensingMedicalMentorsMethodologyMicrobiologyOutcomePharmaceutical PreparationsPoliticsPrivatizationPublic HealthRNA vaccineRecording of previous eventsResearchResearch PersonnelScienceScientistSmallpoxSociologySpeedSurveysSystems BiologyT-LymphocyteTechnologyTestingTimeTranslationsVaccinationVaccinesVirusclinical implementationclinical practicecombatdesignfuture pandemicglobal healthimprovedinnovationinterestmultidisciplinarynew technologynovel therapeuticspandemic diseasepandemic preparednesspathogenpost-COVID-19postersprospectivestructural biologysymposiumvaccine accessvaccine distributionvaccine platformvaccinologyvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Vaccinology During and After COVID-19,
organized by Drs. Bali Pulendran, Robert Seder and Gagandeep Kang. The conference will be held in Atlanta,
Georgia from September 17-21, 2023.
Since its emergence, SARS-CoV-2 has radically transformed practically every dimension of our lives and
fueled an urgent global imperative to develop safe and effective vaccines. The stunning pace at which COVID-
19 vaccines have been developed is unprecedented in the history of vaccinology and has been catalyzed by
the rapid harnessing of innovative new technologies (e.g., mRNA vaccines) and major public and private
investments. The COVID-19 pandemic offered a unique vantage point from which to survey vaccinology as it
was for the past two centuries, since Edward Jenner and the eradication of smallpox, to how it is now, during
the time of COVID-19, and to consider what it could be in the post-COVID era. Equally important has been the
world’s focus on the economics, politics and ethics of how to ensure global equitable access to COVID-19
vaccines. This virus has certainly shone a spotlight on the field of vaccinology as it is, at the focal point of
immunology, microbiology, public health, clinical medicine, economics, sociology, ethics and international
diplomacy. Thus, some talks will also be focused on these broader issues surrounding the field. It is anticipated
that this conference will stimulate debate that helps enhance pandemic preparedness by redefining the way we
conceive of, make, test, license and distribute vaccines globally. Overall, this conference is designed to bring
together an interdisciplinary team of experts to discuss the lessons learnt from the COVID-19 pandemic, with a
particular focus on the immunology of vaccination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
-
批准号:10682118
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
-
批准号:10540260
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
-
批准号:10753451
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Transposable Elements at the Crossroads of Evolution, Health and Disease
-
批准号:10750852
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
-
批准号:10749522
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
批准号:10683443
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
HIV Vaccines, Immunoprophylaxis and Drugs
-
批准号:10699245
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metastasis
-
批准号:10681132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Inflammation in the Lung: Friend or Foe in Viral Infections?
-
批准号:10681956
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
-
批准号:10754008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Myeloid Cell Diversity: From Fundamental Biology to Disease States
-
批准号:10753412
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
RNA Modifications in Health and Disease
-
批准号:10754076
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
-
批准号:10540496
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
From First Breath: Lung Development, Infection, Repair and Aging
-
批准号:10678811
-
项目类别:
-
资助金额:$1.65万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Precision Genome Engineering
-
批准号:10608865
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
T and B Cell Collaboration in Germinal Centers and Beyond
-
批准号:10753621
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
-
批准号:10682747
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metabolic and Molecular Mechanisms of NAFLD/NASH
-
批准号:10682156
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Heart Development and Disease: From Genes to Cures
-
批准号:10608624
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Signals and Mechanisms Underlying the Benefits of Exercise
-
批准号:10750822
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
海外基金